Dr. Paul Rubinstein, MD
Claim this profileUniversity of Illinois
Expert in Lymphoma
Studies Diffuse Large B-Cell Lymphoma
14 reported clinical trials
35 drugs studied
Area of expertise
1Lymphoma
Global LeaderStage IV
Stage III
Stage II
2Diffuse Large B-Cell Lymphoma
Stage IV
Stage III
Stage II
Affiliated Hospitals
Clinical Trials Paul Rubinstein, MD is currently running
Duvelisib/CC-486 + Chemotherapy
for Lymphoma
This phase II trial studies the effect of duvelisib or CC-486 and usual chemotherapy consisting of cyclophosphamide, doxorubicin, vincristine, etoposide, and prednisone in treating patients with peripheral T-cell lymphoma. Duvelisib may stop the growth of cancer cells by blocking some of the enzymes needed for cell growth. Chemotherapy drugs, such as CC-486, cyclophosphamide, doxorubicin, vincristine, etoposide and prednisone, work in different ways to stop the growth of cancer cells, either by killing the cells, by stopping them from dividing, or by stopping them from spreading. This trial may help find out if this approach is better or worse than the usual approach for treating peripheral T-cell lymphoma.
Recruiting1 award Phase 227 criteria
HST-NEETs + Bone Marrow Transplant
for Lymphoma
This is a Phase II multi-center trial single arm trial of autologous transplantation (ASCT) followed by administration of HST-NEETs for treatment of HIV associated lymphoma
Recruiting1 award Phase 2
More about Paul Rubinstein, MD
Clinical Trial Related1 year of experience running clinical trials · Led 14 trials as a Principal Investigator · 9 Active Clinical TrialsTreatments Paul Rubinstein, MD has experience with
- Cyclophosphamide
- Etoposide
- Prednisone
- Ibrutinib
- Rituximab
- Vincristine Sulfate
Breakdown of trials Paul Rubinstein, MD has run
Lymphoma
Diffuse Large B-Cell Lymphoma
B-Cell Lymphoma
Sarcoma
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Paul Rubinstein, MD specialize in?
Paul Rubinstein, MD focuses on Lymphoma and Diffuse Large B-Cell Lymphoma. In particular, much of their work with Lymphoma has involved Stage IV patients, or patients who are Stage III.
Is Paul Rubinstein, MD currently recruiting for clinical trials?
Yes, Paul Rubinstein, MD is currently recruiting for 8 clinical trials in Chicago Illinois. If you're interested in participating, you should apply.
Are there any treatments that Paul Rubinstein, MD has studied deeply?
Yes, Paul Rubinstein, MD has studied treatments such as Cyclophosphamide, Etoposide, Prednisone.
What is the best way to schedule an appointment with Paul Rubinstein, MD?
Apply for one of the trials that Paul Rubinstein, MD is conducting.
What is the office address of Paul Rubinstein, MD?
The office of Paul Rubinstein, MD is located at: University of Illinois, Chicago, Illinois 60612 United States. This is the address for their practice at the University of Illinois.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.